2,5-di-tert-butylhydroquinone has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, SB; Gahm, A; Kass, GE; Llopis, J; Orrenius, S | 1 |
1 other study(ies) available for 2,5-di-tert-butylhydroquinone and Leukemia, T-Cell
Article | Year |
---|---|
Comparison between the effects of the microsomal Ca(2+)-translocase inhibitors thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone on cellular calcium fluxes.
Topics: Animals; Antioxidants; Calcium; Calcium-Transporting ATPases; Cell Line; Cells, Cultured; Cytosol; Fura-2; Humans; Hydroquinones; Kinetics; Leukemia, T-Cell; Liver; Male; Microsomes, Liver; Rats; Rats, Inbred Strains; Signal Transduction; Terpenes; Thapsigargin; Vasopressins | 1991 |